SVNS — Solvonis Therapeutics Share News
0.000.00%
Last trade - 00:00Brief: Solvonis Therapeutics Security Holders Of Awakn Life Sciences Approved Proposed Acquisition Of Awakn By Solvonis
Solvonis Therapeutic - Proposed acquisition of Awakn approved
Solvonis Therapeutic - Final Results for the year ended 31 December 2024
Solvonis Therapeutic - Posting of Circular and Notice of General Meeting
Solvonis Therapeutic - Holding(s) in Company
Brief: Solvonis Therapeutics Says Engaged with Pharmaventures To Support Commercialisation Of Two Clinical-Stage Programmes
Solvonis Therapeutic - Engagement of PharmaVentures
Solvonis Therapeutic - Positive progress on European Patent Application
Solvonis Therapeutic - Update on AWKN-SDN-14 programme
Solvonis Therapeutic - Holding(s) in Company
Solvonis Therapeutic - Appointment of Non-Executive Director
RCS - Solvonis Therapeutic - Presentation at PharmaSynergyRx Event
Solvonis Therapeutic - Entry into an Arrangement Agreement with Awakn
RCS - Solvonis Therapeutic - Proactive Investors interview with Chairman
Solvonis Therapeutic - Update on Awakn Life Sciences’ R&D Progress
RCS - Solvonis Therapeutic - Investor Presentation
RCS - Solvonis Therapeutic - Proactive Investors interview with CEO
Solvonis Therapeutic - Update on FDA Pre-IND Meeting for Awakn
RCS - Solvonis Therapeutic - Interview with CEO